Mesenchymal stromal cell-derived secretome-based therapy for neurodegenerative diseases: overview of clinical trials

BACKGROUND: Over the past few years, mesenchymal stromal cells (MSCs) have attracted a great deal of scientific attention owing to their promising results in the treatment of incurable diseases. However, there are several concerns about their possible side effects after direct cell transplantation,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghasemi, Maryam, Roshandel, Elham, Mohammadian, Mozhdeh, Farhadihosseinabadi, Behrouz, Akbarzadehlaleh, Parvin, Shamsasenjan, Karim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161443/
https://www.ncbi.nlm.nih.gov/pubmed/37143147
http://dx.doi.org/10.1186/s13287-023-03264-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161443/
https://www.ncbi.nlm.nih.gov/pubmed/37143147
http://dx.doi.org/10.1186/s13287-023-03264-0

Ejemplares similares